How to Set Up an Intraocular Lens (IOL) Manufacturing Plant in India: Process, Machinery, Cost, DPR, and CDSCO Approvals (2026)

Introduction

For medical device manufacturers, ophthalmic product companies and industrial investors, an intraocular lens manufacturing plant in India is a precision-optics and regulated-implant project, not a general medical device factory. The lens stays in the eye for life, so surface finish, polymer purity and sterility decide approval and commercial success.

The most expensive mistakes happen early: choosing a lens material before confirming machining capability, building a cleanroom before fixing the process route, or filing for a licence on an unconfirmed device classification. This guide shows how to sequence these decisions and prepare a DPR for a defined production capacity.

IOL projects also carry a long pre-revenue period. Machining trials, process validation, sterilisation studies and shelf-life data take many months, and surgeons adopt a new lens brand cautiously. Funding plans and launch strategy should allow for both.

Scope of this Guide

This guide answers one question: how can investors establish an IOL manufacturing unit in India while evaluating manufacturing technology, precision equipment, regulatory compliance, capital investment and financial feasibility?

It separates full lens manufacturing, from polymer to sterile lens, from limited-scope operations such as finishing, packaging or relabelling imported lenses. It covers lens types, process, machinery, cleanrooms, testing, cost, the DPR, CDSCO approvals, financial risks and a setup checklist. Cost guidance is a framework, not benchmarks.

Table of Contents

• Introduction
• Intraocular Lens Manufacturing in India: Market Demand, Policy Support and Investment Case
• Types of Intraocular Lenses: Materials, Optical Designs and Their Impact on Plant Design
• How to Set Up an Intraocular Lens Manufacturing Unit in India: Step-by-Step Approach
• Intraocular Lens Manufacturing Process: From Lens Blank to Sterile Packaged Lens
• Machinery Required for IOL Manufacturing: Lathes, CNC Mills, Polishing and Metrology
• Cleanroom Requirements, Plant Layout and Utilities for an IOL Manufacturing Plant
• IOL Quality Testing and Validation: Optical, Mechanical, Biocompatibility and Sterility
• Intraocular Lens Manufacturing Plant Cost in India: CAPEX, OPEX and Working Capital
• Preparing a DPR for an Intraocular Lens Manufacturing Plant: Capacity, Costs and Projections
• CDSCO Approvals, Licensing Pathway and Quality Standards for IOL Manufacturing
• Financial Feasibility and Key Project Risks for an IOL Manufacturing Plant
• IOL Manufacturing Plant Setup and DPR Checklist for Investors
• How IMARC Engineering Supports Intraocular Lens Manufacturing Projects in India
• Conclusion

1. Intraocular Lens Manufacturing in India: Market Demand, Policy Support and Investment Case

Four conditions shape the investment case for an intraocular lens manufacturing unit in India, and each affects the plant configuration worth funding.

1.1 Market Applications and Demand Channels

Cataract surgery is among the highest-volume surgical procedures in India, driven by an ageing population and expanding eye-care networks. Modern cataract surgery normally implants an intraocular lens, so demand follows surgical volumes rather than discretionary spending.

Demand flows through three channels: government and charitable eye programmes that buy large volumes at low prices, eye hospital chains that negotiate on volume, and private surgeons who increasingly ask for premium optics. Each channel rewards a different product and price position.

1.2 Project Opportunities by Lens Segment and Customer Type

The opportunity depends on the segment targeted. Volume monofocals, toric lenses and premium multifocal or extended-depth designs differ in technical difficulty, competition and pricing, so the feasibility study should map current domestic and imported supply for each segment, using credible data, before fixing the product range.

Fix the target customer before the lens portfolio. A plant built for high-volume hydrophilic monofocals for eye programmes needs a different design, cost structure and sales effort from one aimed at premium hydrophobic lenses for private hospitals.

1.3 Policy Support and Medical Device Clusters

Central support for medical device manufacturing includes the Production Linked Incentive (PLI) Scheme for medical devices, which was extended up to FY 2035-36 on 10 November 2026, with fresh applications invited under revised guidelines. Applicants should verify the current eligible product categories, investment conditions and application requirements before including any incentive in the project model.

Under the Promotion of Medical Device Parks scheme, parks were approved in Uttar Pradesh (YEIDA), Madhya Pradesh (Ujjain), Tamil Nadu (Oragadam, Kancheepuram) and Himachal Pradesh (Nalagarh). State-led options include AMTZ in Visakhapatnam and the Telangana medical devices park.

Scheme windows, eligibility and park readiness change over time, so confirm current status with the Department of Pharmaceuticals and the relevant state agency before modelling any incentive. Treat incentives as upside, not as the basis of viability. A plant that only works with a subsidy is fragile, because disbursement timing and conditions can change during a long project.

1.4 Key Investment Considerations and Common Early Mistakes

Three failures recur. Lens designs are frozen before machining trials, so surface quality and yield fall short. Cleanrooms are specified before the process route, forcing HVAC rework. Licence applications are filed before the classification, quality system and test evidence are ready, adding months of queries.

A fourth failure is under-budgeting working capital. Many powers and models create slow-moving stock, and hospital customers often take extended credit, so cash needs run well ahead of sales.

2. Types of Intraocular Lenses: Materials, Optical Designs and Their Impact on Plant Design

Lens type drives the whole plant, because each material and optical design needs a different machining, cleaning and sterilisation route.

2.1 Lens Materials: Hydrophobic Acrylic, Hydrophilic Acrylic and PMMA

Hydrophobic acrylic IOLs are foldable and widely associated with lower rates of posterior capsule opacification. Many hydrophobic acrylics are soft at room temperature, so manufacturers often cool them before lathing; the actual machining temperature depends on the polymer and its glass transition temperature.

Hydrophilic acrylic IOLs are usually HEMA-based copolymers, typically machined dry and hydrated afterwards under a validated process. PMMA intraocular lenses are rigid, generally machined at room temperature and low in cost, but need a larger incision, so demand is shifting to foldable designs.

These are common approaches, not universal rules. Machining conditions, any hydration step and the sterilisation method must be set for each material and design, and validated for the specific product.

2.2 Optical Designs: Monofocal, Toric, Multifocal and Extended Depth of Focus

Monofocal lenses correct distance vision with a spherical or aspheric optic. Toric lenses add cylinder power and axis marks to correct astigmatism. Multifocal and extended-depth-of-focus lenses use diffractive or refractive zones to extend the range of clear vision.

Premium designs demand much tighter machining and metrology. Diffractive steps are only micrometres high, and toric lenses need precise axis alignment, so most entrants start with aspheric monofocals and add premium designs once process capability is proven.

2.3 One-Piece and Three-Piece IOL Designs

One-piece lenses machine the optic and haptics from a single blank, which suits acrylic materials and preloaded injectors. Three-piece lenses attach separate haptics, typically PMMA or polypropylene, to the optic, adding assembly steps and inspection points. Optic and haptic design governs centration and stability.

3. How to Set Up an Intraocular Lens Manufacturing Unit in India: Step-by-Step Approach

IOL manufacturing plant setup in India runs through five stages, and each contains decisions that are expensive to reverse.

3.1 Feasibility Study and Lens Portfolio Definition

Start with an intraocular lens manufacturing feasibility study that tests demand, channel pricing, competition and regulatory timelines. Then fix the product portfolio: materials, designs, power range and launch volumes. Every later decision, from machinery to cleanroom class, follows from this definition.

3.2 Full Manufacturing Versus Limited-Scope Operations

Three scopes are common. Finishing, packaging or relabelling imported lenses needs the least capital but offers little control over design or cost. Manufacturing from purchased blanks removes polymer chemistry risk but ties margins to the blank supplier.

Fully integrated production, from monomer casting to sterile lens, adds curing, extraction and chemical safety obligations, but gives the most cost control and design freedom. Many entrants start with purchased blanks and move to in-house casting once volumes justify it.

Regulatory responsibility follows the activity. Under the Drugs and Cosmetics Act, manufacture includes finishing, packing and labelling, so limited-scope operations may still need a manufacturing licence, alongside an import licence for the lenses they bring in. The table summarises each scope.

3.3 Technology Selection: Lathe Cutting Versus Cast Moulding

Choose the forming route by material and volume. Lathe cutting from blanks gives design flexibility and suits most new plants. Cast moulding of finished lenses can lower unit cost at high volumes, but needs precision mould tooling and offers less flexibility. Confirm the route through machining trials.

3.4 Site Selection Criteria for an IOL Manufacturing Plant

Choose a site with stable power, vibration-free ground, low dust exposure, access to sterilisation and testing services, and a pool of trainable technicians. Avoid locations near heavy road, rail or press-shop vibration, which cannot be engineered away cheaply once lathes are installed.

3.5 Project Execution Sequence: From Machining Trials to Commissioning

Execution follows a fixed order: machining trials, detailed engineering, long-lead equipment orders, cleanroom construction, equipment qualification, process validation, licence application, sterilisation and shelf-life studies, and plant commissioning. Regulatory and validation work should run in parallel with engineering, not after it.

4. Intraocular Lens Manufacturing Process: From Lens Blank to Sterile Packaged Lens

The intraocular lens manufacturing process combines polymer chemistry, ultra-precision machining and medical device quality control. The steps below describe full manufacturing; blank-based plants start at lathe cutting.

4.1 Lens Blank Preparation

In integrated plants, filtered and degassed monomer mixes with crosslinkers, initiators and UV absorbers are cast into rods or sheets and cured under nitrogen on a controlled temperature profile. Residual monomer is then removed by extraction and checked by chromatography.

Blanks are cut into buttons, conditioned to relieve stress and tested lot by lot for machinability. Curing defects such as bubbles, voids or uneven stress later appear as machining failures or optical haze, so cure control is a yield lever, not just a chemistry step.

4.2 Precision Lathe Cutting of the Optic

Ultra-precision diamond-turning lathes cut the anterior and posterior optic surfaces that set lens power and asphericity. Cutting temperature depends on the material: many hydrophobic acrylics are cut cooled, while hydrophilic acrylic and PMMA are often cut at or near room temperature, as qualified for each polymer. Thermal stability, vibration isolation and tool condition control surface form and finish.

Cutting programmes, feed rates and tool geometry are material-specific. A documented process window, with first-article checks after each tool change, keeps power consistent from lens to lens.

4.3 CNC Machining of Haptics and Edges

For one-piece lenses, CNC micro-milling cuts the haptics and optic edge from the turned blank. Three-piece lenses have holes drilled in the optic to hold separate haptics. A sharp, well-finished posterior edge helps limit posterior capsule opacification, so edge profile is a defined control point.

4.4 Lens Polishing, Cleaning and Hydration

Tumble polishing with fine media removes tool marks and smooths non-optical edges under controlled time and temperature. Ultrasonic cleaning, using purified water and any solvents qualified for the lens material, then removes particles and residues. Hydrophilic lenses go through a validated hydration step and are checked for water content and power shift.

Polishing must remove marks without distorting the optic, so batch size, media wear and fluid condition are monitored. Cleaning validation must show that no polishing or solvent residue remains.

4.5 Lens Inspection, Packaging and Sterilisation

Every lens is inspected individually under magnification, or by automated vision, for scratches, voids, haze and edge defects, and tested for power and image quality. Accepted lenses are packed in validated sterile barrier systems and sterilised by a method selected and validated for the specific material, design and packaging. Ethylene oxide and moist heat are both used.

5. Machinery Required for IOL Manufacturing: Lathes, CNC Mills, Polishing and Metrology

IOL manufacturing machinery accounts for a large share of capital and most technical risk, so selection should be driven by proven performance on the buyer's own lens design.

5.1 Precision Lathes and CNC Machines

Ultra-precision diamond-turning lathes are the core asset. Specify them on form accuracy, surface roughness, thermal stability and spindle performance, with cooling capability where the chosen material needs it. CNC micro-mills handle haptics and edges. Most of this equipment is imported, with long lead times.

Make acceptance trials on your own lens design part of the purchase contract, and tie vendor commitments to surface quality, installation, operator training, tooling support and local service response.

5.2 Moulding Equipment Where Applicable

Cast moulding of finished lenses or optics needs precision mould tooling, dosing and curing equipment and mould inspection. It suits high, stable volumes of a narrow design range and is rarely the first choice for a new plant.

5.3 Polishing and Cleaning Equipment

Tumble polishers with controlled media and fluid, multi-stage ultrasonic cleaning lines, purified-water systems and drying equipment complete the finishing line. Hydrophilic lines also need hydration and equilibration tanks.

5.4 Inspection and Optical Metrology

Optical metrology equipment measures lens power, modulation transfer function (MTF) and resolution to ISO 11979-2. Interferometers or surface profilers check optic form, and microscopes, profile projectors or vision systems handle cosmetic and dimensional inspection. Mechanical testers cover the haptic tests in ISO 11979-3.

Where ethylene oxide is used, sterilisation is often contracted to a validated external facility, so transport and scheduling belong in the lead-time plan.

6. Cleanroom Requirements, Plant Layout and Utilities for an IOL Manufacturing Plant

Medical device cleanroom manufacturing for IOLs should be specified by process step and contamination risk, not by a single blanket class.

6.1 Cleanroom Classification for IOL Manufacturing Areas

Cleanroom classifications should be determined through a documented contamination-control risk assessment, considering the lens material, manufacturing process, cleaning requirements, product exposure and sterile-barrier packaging operations. The selected ISO 14644-1 classification, environmental monitoring and qualification requirements should be justified for each production area.

6.2 HVAC and Contamination Control

HVAC must hold stable temperature and humidity for machining accuracy and material stability, with pressure cascades between zones, gowning airlocks and pass boxes. India's monsoon humidity and dust loads raise HVAC duty, so dehumidification and filtration need generous margins.

Routine monitoring of particles, pressure differentials, temperature and humidity, plus periodic requalification, keeps the cleanroom within its validated state.

6.3 Plant Layout and Personnel and Material Flow

Layout should flow in one direction from stores through casting, machining, cleaning, inspection and packaging to quarantine and dispatch, with separate routes for personnel, materials and waste. Lathes need vibration-isolated foundations, and monomer and solvent areas need segregation and ventilation.

6.4 Utilities and Chemical Safety

Key utilities are stable power with UPS for lathes and metrology, DG backup, purified water, oil-free compressed air, nitrogen for casting and redundant HVAC chillers. Utility loads depend on capacity and process route, so size them from equipment data rather than generic benchmarks.

Monomers and solvents need cool, flameproof, ventilated storage with spill containment, and staff should be trained on methacrylate sensitisation risks. Workplace safety obligations follow the Occupational Safety, Health and Working Conditions Code, 2020 and the applicable state rules.

7. IOL Quality Testing and Validation: Optical, Mechanical, Biocompatibility and Sterility

Testing and validation turn machined lenses into documented, sterile and traceable implants that regulators and surgeons will accept.

7.1 Optical Performance Testing

Optical testing measures dioptric power, image quality (MTF) and spectral transmittance using ISO 11979-2 methods, with power tolerances that widen at higher powers. Every lens is also inspected for cosmetic defects, with defect catalogues and inspector requalification keeping judgments consistent.

7.2 Dimensional and Mechanical Inspection

Dimensional checks cover optic and overall diameter, thickness, haptic angle and edge profile. ISO 11979-3 mechanical tests include haptic compression force, axial displacement, optic decentration and tilt, and dynamic fatigue. Destructive tests consume lenses, so sampling plans belong in the yield model.

7.3 Material Evaluation and Biocompatibility Testing

Material evaluation covers refractive index, water content for hydrophilic grades, residual monomer and extractables, and glistenings for acrylics. Biocompatibility testing follows ISO 10993-1 and ISO 11979-5 at accredited laboratories, and should start early because some studies take months.

7.4 Sterilisation Validation and Shelf Life

Sterilisation must be validated for each product family, covering lens material, design, packaging and load configuration. Ethylene oxide is validated to ISO 11135 and moist heat to ISO 17665, typically to a sterility assurance level of 10^-6, with routine monitoring and revalidation after significant changes.

Where ethylene oxide is used, residues of ethylene oxide and ethylene chlorohydrin must meet ISO 10993-7 limits. The sterile barrier system is validated to ISO 11607-1 for materials and design and ISO 11607-2 for forming, sealing and assembly, including seal strength and package integrity.

Shelf life and transport stability are demonstrated to ISO 11979-6 through real-time or accelerated ageing that covers optical and mechanical properties, sterility maintenance and package integrity. The labelled expiry must be supported by data on the final sterilised product in its commercial packaging.

7.5 Process Validation, Risk Management and Traceability

Process validation (IQ, OQ, PQ) covers casting, machining, cleaning, packaging and sterilisation. ISO 14971 risk management links hazards to controls, and lot traceability ties each lens to its polymer batch, machine run, operator, sterilisation cycle and test data.

8. Intraocular Lens Manufacturing Plant Cost in India: CAPEX, OPEX and Working Capital

Intraocular lens manufacturing plant cost depends on scope, materials, designs, capacity and automation, so it should be built from quotations rather than generic benchmarks. The framework below shows what to include.

8.1 CAPEX Components of an IOL Manufacturing Plant

Capital cost covers land or lease, building and civil works, cleanrooms and HVAC, machinery, metrology and QC laboratory equipment, utilities, installation and qualification, engineering and project management, validation and regulatory work, pre-operative expenses and contingency.

8.2 OPEX Components and Recurring Cost Drivers

Operating cost covers lens blanks or monomers, haptic material, diamond tooling, polishing media, packaging, sterilisation, labour, utilities, testing, maintenance, calibration, quality assurance and regulatory upkeep. Tooling wear and testing consumables are often underestimated.

8.3 Working Capital Requirements for an IOL Plant

Working capital covers raw material and packaging inventory, work in progress during validation and sterilisation release, finished stock across many powers, and receivables from hospitals and distributors that often take extended credit.

9. Preparing a DPR for an Intraocular Lens Manufacturing Plant: Capacity, Costs and Projections

An IOL manufacturing project report, or intraocular lens plant DPR, should tie every cost and revenue line to verifiable technical assumptions. The table below sets out what a bankable DPR should cover.

9.1 Calculating CAPEX and OPEX

CAPEX estimation is built bottom-up from quotations for each cost head, plus contingency. OPEX planning works per saleable lens: material and tooling cost adjusted for cumulative yield, plus labour, utilities, testing, sterilisation and overheads spread over saleable output.

9.2 Capacity, Yield and Ramp-Up

State capacity as saleable lenses per year at a defined yield and utilisation, not as machine count. Calculate the throughput of each stage, including casting, lathing, haptic machining, polishing, cleaning, inspection, packaging and sterilisation lead time, from equipment data, staffing and shifts. The slowest stage in the specific project sets installed capacity.

Model a realistic ramp-up, with lower utilisation and yields in the first year, plus the pre-revenue period of validation and regulatory work. These periods usually decide whether debt service holds.

The tables below show the method with hypothetical figures only. They are not benchmarks for any real plant; actual rates must come from machining trials, vendor data and the project's own shift plan.

In this example, lathing is the slowest stage, so it sets installed capacity. In another project, inspection, polishing or sterilisation lead time could be the constraint.

9.3 Financial Projections: DSCR, NPV, IRR and Break-Even

Projections should show revenue by product and channel, operating cash flow, DSCR, NPV, IRR and break-even, with sensitivity tests on yield, selling price, utilisation and approval timing. Lenders rely on these outputs for project financing decisions.

10. CDSCO Approvals, Licensing Pathway and Quality Standards for IOL Manufacturing

CDSCO approval for IOL manufacturing is the main regulatory gate. IOLs were among the first medical devices brought under regulation in India and are now governed by the Medical Devices Rules, 2017.

10.1 Device Classification of IOLs under the Medical Devices Rules, 2017

CDSCO lists intraocular lenses as Class C, moderate-to-high risk, devices under the Medical Devices Rules, 2017. Confirm the entry for each lens model in CDSCO's current classification list before filing, as the lists are revised from time to time.

10.2 Manufacturing Licence Pathway

As a Class C device, an IOL needs a manufacturing licence from the Central Licensing Authority at CDSCO. The manufacturer applies online on Form MD-7 with device and plant master files, and the licence is issued on Form MD-9 after document review and site inspection.

A company without its own plant can instead apply for a loan licence, on Form MD-8 with the licence issued on Form MD-10, to manufacture at another manufacturer's licensed premises. The loan licensee remains responsible for the device it places on the market.

A test licence may be needed to make units for testing or evaluation before the manufacturing licence. Check current forms, fees and portal procedures with CDSCO at the time of filing.

10.3 Quality Management System and ISO Standards

Build the quality system on ISO 13485, which aligns with the quality management requirements of the Medical Devices Rules. ISO 14971 governs risk management, and the ISO 11979 series sets IOL-specific requirements.

10.4 Other Approvals: Pollution Control, Factory, Fire and PESO Clearances

Other approvals typically include State Pollution Control Board consents, factory plan approval and licence under the OSH Code where thresholds are met, fire safety approval, hazardous waste authorisation for solvent and monomer waste, and PESO licensing if solvent storage exceeds exemption limits.

11. Financial Feasibility and Key Project Risks for an IOL Manufacturing Plant

Profitability depends less on headline capacity than on how many good lenses the plant sells, at what price and in what mix.

11.1 Yield and Rejection Rates

Yield is the biggest single lever. Each stage, from casting to inspection, removes lenses, and cumulative yield sets the real cost per saleable lens. Model rejection by stage and test downside cases.

11.2 Product Mix, Pricing and Utilisation

Premium designs earn higher prices but need tighter tolerances and longer validation. Volume monofocals sell into price-sensitive tenders and eye programmes. Utilisation determines how fixed costs spread across output, so sales channels should be secured before capacity is added.

11.3 Cash Flow and Key Risks

Key risks include delayed licensing, slow surgeon adoption, yield shortfalls, dependence on imported blanks and machines, tender price pressure and working capital strain from long credit periods. Mitigation includes phased capacity, supplier qualification and conservative ramp-up assumptions.

11.4 Sensitivity Analysis for Base, Downside and Upside Cases

Run sensitivities on yield, average selling price, product mix, utilisation, approval timing, imported input costs and exchange rates. Base, downside and upside cases show lenders how DSCR responds.

12. IOL Manufacturing Plant Setup and DPR Checklist for Investors

Use this checklist before committing capital and again before commissioning.

13. How IMARC Engineering Supports Intraocular Lens Manufacturing Projects in India

IMARC Engineering supports IOL projects with feasibility studies, DPR preparation, plant layout and cleanroom planning, equipment selection and sourcing, regulatory approval support and project management through to commissioning.

The scope of each engagement is defined with the client, whether the project is a finishing operation, a blank-based plant or a fully integrated intraocular lens production facility.

Conclusion

A bankable intraocular lens manufacturing plant in India aligns lens portfolio, machining capability, cleanroom design and regulatory evidence before capital is committed. Investors who fix the product and route first, prove yields through trials and build the DPR on rejection-adjusted capacity avoid the costliest failures.

A phased strategy often balances risk and return: start with a defined monofocal range, prove yield and regulatory compliance, build surgeon trust, then add toric and premium designs as capability and cash flow allow.